Welcome

Sign out Have a question? We're here to help

Copyright © 2019 InvestorPlace Media, LLC. All rights reserved. 9201 Corporate Blvd, Rockville, MD 20850.

Ultra Nasdaq Biotech Proshares (BIB)

$47.82 1.41 (2.86%)

15:59 EDT BIB Stock Quote Delayed 15 Minutes

Volume:

Previous Close $47.82

Market Cap 334.74M

PE Ratio -

EPS -

Volume (Avg. Vol.) 120,600

Day's Range 47.71 - 49.46

52-Week Range 36.05 - 70.82

Dividend & Yield N/A (N/A)

BIB Stock Predictions, Articles, and Ultra Nasdaq Biotech Proshares News

From InvestorPlace
From the Web

3 ETFs to Watch on Biotech Earnings

By Zacks Investment Research Nov 6, 2017

Major Biotech companies report mixed Q3 results.

Can Biotech Stocks Bounce Back?

By Hilary Kramer, Editor, GameChangers Feb 19, 2016

The biotech sector has been under pressure for months, and things aren't likely to improve anytime soon. Here's what's ailing biotech stocks.

Be Careful Before Loving Leveraged Biotech ETFs

By Todd Shriber, InvestorPlace Contributor Oct 6, 2015

The new crop of triple-leveraged biotech ETFs have had staggering returns (and losses), serving as a reminder that not all investors should be involved with leveraged ETFs.

4 Biotech Stocks Poised to Jump 15%

By Profit Scanner Apr 23, 2015

Biotech stocks are continuing to do well on Wall Street, but these four stocks have all the technical signs of making a big leap soon.

Biotech ETFS: How To Pick Biotech Stock Winners And Avoid Volatility In 2019

From Investor's Business Daily Jan 24, 2019

Biotech ETFs allow investors to buy into a basket of biotech stocks, rather than trying to select specific winners. The best biotech ETFs have a diverse number of biotech stocks and the ability to supersede volatility in the market to put up regular gains.

Acceleron Pharma Soars On Celgene-Partnered Anemia Treatment

From Investor's Business Daily Jun 29, 2018

Acceleron Pharma rocketed early Friday after it and Celgene reported strong results for a partnered anemia treatment called luspatercept. The biotech companies are now working toward approval of the drug.

Biotech Funds Tacked On $76 Million This Week — Are They Recovering?

From Investor's Business Daily Jun 15, 2018

Biotech funds tacked on $76 million this week, helped by biotech ETFs, and adding to more than $500 million in net inflows over the past two weeks. It's a phenomenon biotech stocks haven't seen in nine months.

Stock Charts Today - Monday, June 11

From TalkMarkets Jun 11, 2018

A review of today's markets.

Three ETFs to Watch on Biotech Earnings

From TalkMarkets Feb 12, 2018

The earnings season is off to a flying start, owing to a slew of upbeat economic data, strong corporate performance, and President Donald Trump's tax reform signed into law.

2018 Stock Market Forecast - Inflation

From TalkMarkets Jan 2, 2018

Inflation broke out to multi year highs in 2017 and we expect rising interest rates and rising inflation in 2018.

Free Report

10 Stocks Set for Monster Growth

He found Apple at $4… Oracle at $6… Amazon at $40… Now legendary growth investor Louis Navellier is giving away his latest Research Report — for FREE!

Download your FREE COPY!